Stefan Lutz - 23 Feb 2026 Form 4 Insider Report for CODEXIS, INC. (CDXS)

Role: Chief Scientific Officer
Signature: /s/ Georgia Erbez, as Attorney-in-Fact for Stefan Lutz
Issuer symbol: CDXS
Transactions as of: 23 Feb 2026
Net transactions value: -$6,641
Form type: 4
Filing time: 25 Feb 2026, 19:54:29 UTC
Previous filing: 09 Feb 2026
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Lutz Stefan	Chief Scientific Officer	C/O CODEXIS, INC., 200 PENOBSCOT DRIVE, REDWOOD CITY	/s/ Georgia Erbez, as Attorney-in-Fact for Stefan Lutz	25 Feb 2026	0002094828

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CDXS	Common Stock	Sale	$6,641	-5,862	-4.3%	$1.13	130,421	24 Feb 2026	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CDXS	Stock Option (Right to Buy)	Award	$0	+316,100		$0.000000	316,100	23 Feb 2026	Common Stock	316,100	$1.07	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The shares were sold solely to satisfy tax or other government withholding obligations in connection with the vesting of shares subject to Restricted Stock Units ("RSUs") of the Issuer.
F2	Includes 23,299 RSUs.
F3	This option vests and becomes exercisable with respect to 25% of the shares subject thereto on the first anniversary of the grant date, and with respect to 1/48th of the original number of shares subject thereto on each monthly anniversary thereafter, subject to the Reporting Person's continued employment through the applicable vesting dates.